To include your compound in the COVID-19 Resource Center, submit it here.

Merck KGaA biosimilars news

Merck said it would invest EUR130 - EUR150 million ($168.2-$194.1 million) in biosimilars during 2015,

Read the full 152 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE